Scholarly Index
Daniel M. Geynisman
Fox Chase Cancer Center; 5,439 total citations; 283 total publications; best world rank #67
Fox Chase Cancer Center
5,439Total citations
283Total publications
39H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Economic and Financial Impacts of Cancer | Lifetime | 284 | US 185 | 96.77 |
| Bladder and Urothelial Cancer Treatments | Lifetime | 685 | US 306 | 97.43 |
| Renal cell carcinoma treatment | Lifetime | 796 | US 402 | 96.97 |
| Urinary and Genital Oncology Studies | Lifetime | 561 | US 247 | 96.51 |
| Bladder and Urothelial Cancer Treatments | 2021-2025 | 89 | US 37 | 98.75 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 67 | US 38 | 97.12 |
| Urinary and Genital Oncology Studies | 2021-2025 | 70 | US 30 | 98.04 |
| Renal cell carcinoma treatment | 2021-2025 | 173 | US 70 | 97.11 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 683 | US 252 | 97.39 |
| Renal and related cancers | 2021-2025 | 211 | US 90 | 93.60 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 395 | US 142 | 79.70 |